FDA Import Refusal SCS-0140169-6/11/1 — Lilly del Caribe, Inc.
The FDA refused shipment SCS-0140169-6/11/1 from Lilly del Caribe, Inc. (United States) on May 13, 2020. The refused product falls under Drugs and Biologics — TADALAFIL. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 13, 2020
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66SCA51 TADALAFIL
- Charges
- 75